Cyberattack halts Tissue Regenix's U.S.-based manufacturing operations

Cyberattack halts Tissue Regenix's U.S.-based manufacturing operations

U.K.-based medical technology company Tissue Regenix acknowledged on Tuesday that it took its systems offline after an unauthorized party accessed them and those of its U.S.-based third-party IT service provider.


According to a report from Reuters, the Leeds-based company said the shutdown will negatively impact its ability to manufacture products at its U.S. facility in the short term. U.K.-based and financial systems are apparently not affected.


Tissue Regenix reportedly has not indicated when the intrusion took place or when it was discovered. The company did say that it has hired experts to investigate the intrusion and has also contacted legal officials.


On its website, Tissue Regenix describes itself as a company “focusing on the development of regenerative products utilizing our two platform technologies” – one that addresses soft tissue needs, and another that provides inductive bone allografts. Its three areas of medical specialization are biosurgery, orthopedics and dental, and cardiac. SC Media reached out to Tissue Regenix for further comment on the incident.


Reuters reported that shares in the company dropped as much as 22 ..

Support the originator by clicking the read the rest link below.